Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

ASTRO's new guidelines enhance radiation therapy strategies for gastric cancer, improving treatment outcomes and patient care ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

FYR Bio ("FYR"), a leader in liquid-biopsy precision medicine for neuro-oncology, today announced a collaboration with NuvOx Therapeutics, Inc. ("NuvOx") supported by a two-year $1,976,897 ...

Key recommendations from the guideline are as follows: ...

Barbara Burtness, MD highlights key news in head and neck cancer from ESMO 2025, including CAMORAL, ASPEN-03 & -04, OrigAMI-4 & -05 results.

The Head and Neck Cancer Drugs/Therapeutics Market is experiencing substantial growth, valued at USD 4.2 Billion in 2024 and projected to reach USD 8.5 Billion by 2033. This expansion reflects ...

Researchers sought to develop and validate artificial neural networks for overall survival and progression-free survival in older adults with HNSCC following definitive chemoradiation.

Guardant Health’s accepted abstracts span multiple tumor types, including lung, colorectal, breast, head and neck, and cancers of unknown primary. Together, they underscore the company’s commitment to ...

A daily pill called osimertinib (Tagrisso) is delivering far longer cancer control for adults with unresectable stage 3 EGFR-mutated non-small cell lung cancer after chemoradiation and is now ...

Tecentriq with chemoradiation improved long-term quality of life in limited-stage small cell lung cancer without increasing fatigue. Twice-daily radiation showed better survival and quality of life ...

Researchers at Fox Chase Cancer Center have demonstrated that pulsed low dose rate (PLDR) chemoradiation therapy can significantly reduce side effects while maintaining treatment effectiveness for ...